The latest report is the most recent study that offers 360° coverage of the Pediatric Psoriasis industry that has been facing the brunt of the adverse economic impact of the COVID-19 outbreak since the beginning of this year. The global health crisis has affected nearly every aspect of the business vertical and led to massive disruptions to the global Pediatric Psoriasis market demand and supply chains. Researchers draw predictions for the market scenario in the post-COVID era. The report, additionally, assesses the present market situation and estimates its future outcomes, keeping in mind the impact of the pandemic on the global economic landscape.

The promising drug pipeline will further propel the demand for the advanced medication in the long run. This trend is expected to propel over the forecast period as the prevalence rate has been increasing. Hence, a thorough understanding approach is required for disease management, which would certainly help manage childhood psoriasis better. However, lack of awareness in emerging economies and insufficient research funding may hamper the market.

Get a Free sample of the report :

The childhood population has very few approved treatment options for infantile psoriasis. Furthermore, to broaden the therapeutic options, key market players are taking vital initiatives to expand their product offerings. According to the Indian Society of Pediatric Dermatology, the incidence is expected to increase with age and is reported to be nearly 0.55% in the age group of 0–9 years. Moreover, Pharmaceutical and biopharmaceutical companies anticipate high market growth in the coming future. For instance, in July 2020, FDA approved Ustekinumab for plaque psoriasis in kids

Key participants include AbbVie Inc.; Amgen Inc.; Johnson & Johnson; Novartis AG; Eli Lilly & Company; AstraZeneca; Celgene Corporation; UCB; and Merck, Boehringer Ingelheim and LEO Pharma and others.

Key Highlights from the Report

The North America Pediatric psoriasis market is anticipated to dominate the in the global market. Increasing awareness of the disease and favorable research funding scenario and government initiatives, and high medical reimbursement facilities are the major driving factors for the growth of this market.

Other factors such as increasing awareness regarding treatments coupled with snowballing prevalence in the countries like U.S will provide traction to the market. According to the International Federation of Psoriasis Association, nearly 100,000 new cases are registered and reported every year. However, associated side effects associated with the treatment is expected to hamper the market.

Based on type segment, plaque psoriasis are expected to have the largest market share among the other segments during the forecast period. This is attributed to the highest prevalence of the disease in children. Moreover, it is most common form psoriasis. According to the National Psoriasis Foundation (NPF), if a parent has psoriasis, child’s chances of developing psoriasis increases by 10%.

The market is widely driven by increasing demand for therapies. Moreover, the understanding about the disease and therapeutic has expanded greatly owing to the increased demand of therapy in the near future. For instance, childhood psoriasis has a better prognosis as compared to adult onset psoriasis.

Segmental Analysis

The global Pediatric Psoriasis market is broadly segmented on the basis of different product types, application range, end-use industries, key regions, and an intensely competitive landscape. This section of the report is solely targeted at readers looking to select the most appropriate and lucrative segments of the Pediatric Psoriasis sector in a strategic manner. The segmental analysis also helps companies interested in this sector make optimal business decisions and achieve their desired goals.

Request customization of the report:

Emergen research have segmented into the global Pediatric psoriasis market on the basis of type, treatment, end use, and region:

Type Outlook (Revenue, USD million; 2017-2027)

  • Plaque psoriasis
  • Guttate psoriasis
  • Pustular psoriasis
  • Inverse psoriasis
  • Erythrodermic psoriasis
  • Mucosal/oral psoriasis
  • Nail psoriasis
  • Napkin or diaper psoriasis
  • Photosensitive psoriasis
  • Flexural psoriasis

Treatment Outlook (Revenue, USD million; 2017-2027)

  • Topical therapy
  • Oral
  • Injections
  • Biologics
  • Natural supplements
  • Phototherapy

End Use Outlook (Revenue, USD million; 2017-2027)

  • Hospitals
  • Specialty Clinics
  • Ambulatory Care Centers
  • Research Organizations

Regional Analysis of the Pediatric Psoriasis Market:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Rapid Business Growth Factors

In addition, the market is growing at a fast pace and the report shows us that there are a couple of key factors behind that. The most important factor that’s helping the market grow faster than usual is the tough competition.

Let us know if you have any specific requirements. We offer report customization.

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

Key Points of Pediatric Psoriasis Market:

Extensive coverage of the analysis of the Pediatric Psoriasis market

Key insights into the regional spread of the industry in key geographies

Radical insights into the vital market trends; both current and emerging trends, and factors influencing the growth of the market

Comprehensive coverage of the impact of the COVID-19 pandemic on the overall growth of the Pediatric Psoriasis market

Complete data about the key manufacturers and vendors in the Pediatric Psoriasis market

Read More:

Related reports:

rfid in healthcare market

nucleic acid isolation and purification market

non-invasive prenatal testing market

in-vitro fertilization market

medical image analytics market

joint reconstruction devices market

precision medicine market

microfluidics market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research         and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs